Last reviewed · How we verify

Intraoperative anesthetic strategy by Desflurane — Competitive Intelligence Brief

Intraoperative anesthetic strategy by Desflurane (Intraoperative anesthetic strategy by Desflurane) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: General anesthetic. Area: Anesthesiology.

phase 2 General anesthetic GABA_A receptor Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Intraoperative anesthetic strategy by Desflurane (Intraoperative anesthetic strategy by Desflurane) — Assistance Publique - Hôpitaux de Paris. GABA receptor antagonist

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Intraoperative anesthetic strategy by Desflurane TARGET Intraoperative anesthetic strategy by Desflurane Assistance Publique - Hôpitaux de Paris phase 2 General anesthetic GABA_A receptor
SAGE-547 SAGE-547 Supernus Pharmaceuticals, Inc. phase 3 antisense oligonucleotide GABA_A receptor alpha 1 subunit
Sevoflurane + Remifentanyl Sevoflurane + Remifentanyl Azienda Ospedaliera San Gerardo di Monza phase 3 General anesthetic and opioid analgesic GABA_A receptor and opioid receptors
Sevoflurane, Sufentanil Sevoflurane, Sufentanil University of Saskatchewan phase 3 General anesthetic, Opioid analgesic GABA_A receptor, Mu-opioid receptor
topiramate, propranolol topiramate, propranolol Johnson & Johnson Pharmaceutical Research & Development, L.L.C. phase 3 Anticonvulsant Voltage-dependent sodium channels, GABA_A receptor
Sevoflurane intravenous anesthesia Sevoflurane intravenous anesthesia The Cleveland Clinic phase 3 Volatile anesthetic GABA_A receptor
intravenous sedation with propofol intravenous sedation with propofol University Hospital, Clermont-Ferrand phase 3 GABA_A receptor agonist GABA_A receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (General anesthetic class)

  1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  2. Chung-Ang University Gwangmyeong Hospital · 1 drug in this class
  3. Fresenius Kabi · 1 drug in this class
  4. Gangnam Severance Hospital · 1 drug in this class
  5. Rigshospitalet, Denmark · 1 drug in this class
  6. Seoul National University Hospital · 1 drug in this class
  7. Universidade Estadual Paulista Júlio de Mesquita Filho · 1 drug in this class
  8. University Health Network, Toronto · 1 drug in this class
  9. Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intraoperative anesthetic strategy by Desflurane — Competitive Intelligence Brief. https://druglandscape.com/ci/intraoperative-anesthetic-strategy-by-desflurane. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: